Home | Site Index | Contact | Disclaimer   

 

 
     

LEGAL INFORMATION & NOTICES (DISCLAIMER)

 

 

1. Introduction

The information, pictures, graphics, publications and other information and content (collectively, the “Content”) on this website provided by Antares Pharma Inc. ("Antares") are for informational purposes only.



2. Content

 

This website and the Content on this website contain forward-looking statements within the meaning of Section 27A of the Securities Act, Section 21E of the Securities Exchange Act of 1934, as amended, or the Exchange Act, and the Private Securities Litigation Reform Act of 1995 that are subject to risks and uncertainties. You should not place undue reliance on those statements because they are subject to numerous uncertainties and factors relating to Antares' operations and business environment, all of which are difficult to predict and many of which are beyond Antares' control. These statements often include words such as "may," "believe," "expect," "anticipate," "intend," "plan," "estimate" or similar expressions. These statements are based on assumptions that Antares made in light of its industry experience as well as its perceptions of historical trends, current conditions, expected future developments and other factors Antares believes are appropriate under the circumstances. As you read and consider the Content of this website, you should understand that these statements are not guarantees of performance results. They involve risks, uncertainties and assumptions. Although Antares believes that these forward-looking statements are based on reasonable assumptions, you should be aware that many factors could affect Antares' actual financial results or results of operations and could cause actual results to differ materially from those in the forward-looking statements. You should keep in mind that a forward-looking statement made by Antares on this website speaks only as of the date of publication of that statement on this website. Actual results could differ materially from those currently anticipated as a result of a number of risk factors, including, but not limited to, the risks and uncertainties discussed in Antares' filings with the Securities and Exchange Commission. New risks and uncertainties come up from time to time, and it is impossible for Antares to predict these events or how they may affect Antares. Antares has no duty to, and does not intend to update or revise the forward-looking statements on this website after the date of publication on the website. In light of these risks and uncertainties, you should keep in mind that any forward-looking statement on this website or elsewhere might not occur.



3. Trademark Information

Use of any Antares trademark, trade name, service mark or other logo or mark is prohibited, unless expressly authorized in writing in advance by Antares.



4. Notice of Copyright

The Content is protected by U.S. and international copyright law and may not be copied (except as necessary to view this website in your web browser), distributed, modified or reproduced, in whole or in part, without the prior written permission of Antares. This website and all Content are Copyright © 2007 Antares Pharma Inc., which reserves all of its rights.



5. Copyright Infringement Policy

Antares is committed to complying with copyright and related laws, and expects all users of the website to comply with such laws as well. You may not use our website to transmit (whether by e-mail, uploading, posting, or otherwise) any information or items without the express permission of the owner of such information or items or to engage in any activity that infringes any copyright or any other right of a third party. By uploading or providing Antares with any information or data, you represent and warrant to Antares that (a) you own, or are otherwise lawfully authorized to use, any files, data, text, or other information that you may transmit to or through our website and (b) any use of the files, data, text, or other information supplied by you does not violate the rights of Antares or any other person or entity and will not cause injury to any person or entity.



6. Claims of Copyright Infringement

If you believe that your work has been copied on our website, or any of Antares' other systems or networks in a way that constitutes infringement under the Copyright Act, please provide Antares a notice of claimed infringement that complies with the requirement of the Digital Millennium Copyright Act, 17 U.S.C. § 512(c)(3) and which may include:

 

  • An electronic or physical signature of the person authorized to act on behalf of the owner of the copyright interest;

  • A description of the copyrighted work that you claim has been infringed;

  • A description of where the material that you claim is infringing is located on the website;

  • Your name, title (if applicable), address, telephone number and e-mail address;

  • A statement by you that you have a good faith belief that the disputed use is not authorized by the copyright owner, its agent or the law; and

  • A statement by you, made under penalty of perjury, that the above information in your notification is accurate and that you are the copyright owner or authorized to act on the copyright owner's behalf.

 

Antares may be contacted at:

By Mail:

 

Antares Pharma Inc.
Princeton Crossroads Corporate Center
250 Phillips Boulevard, Suite 290
Ewing, NJ 08618
United States of America


By Phone: +1 (609) 359 3020
By Fax: +1 (609) 359 3015
By E-mail: sbaldwin@antarespharma.com



7. Privacy

Your privacy is important to Antares. We understand you may have questions or concerns regarding your personal information and how it will be used. Accordingly, we have a developed a Privacy Policy (which may be modified by Antares from time to time) to explain our privacy-related practices. You may view our Privacy Policy by clicking [ HERE ].



8. Links to and from Third Party Websites

This website may include links or references to other websites maintained by third parties over whom Antares has no control. Such links and references are provided as a convenience and shall not be construed to imply any particular relationship with such third parties. Similarly, this website may be accessed from third party links over which Antares has no control. The third party providers of such websites shall be solely responsible for the accuracy, currency or completeness of any information contained in or on such websites.



9. Third Party Information

This website may contain information provided by third parties. The third party provider shall be solely responsible for its accuracy, currency and completeness of such information.



10. Warranties and Disclaimers

ALL CONTENT PROVIDED ON OR THROUGH THE WEBSITE IS PROVIDED "AS IS" AND "AS AVAILABLE." ANTARES EXPRESSLY DISCLAIMS ALL WARRANTIES AND/OR CONDITIONS, EXPRESS OR IMPLIED, AS TO ANY MATTER WHATSOEVER RELATING TO OR REFERENCED BY OR ON THE WEBSITE, INCLUDING, WITHOUT LIMITATION, ANY IMPLIED WARRANTIES OF MERCHANTABILITY, FITNESS FOR A PARTICULAR PURPOSE, SATISFACTORY QUALITY, TITLE OR NON-INFRINGEMENT.



11. Contact Information

ANTARES PHARMA INC.

Princeton Crossroads Corporate Center
250 Phillips Boulevard, Suite 290
Ewing, NJ 08618
United States of America

Tel.: +1 (609) 359 3020
Fax: +1 (609) 359 3015
 

 

 

 

 

 

 

 

Navigation Main:  Company Overview  |  Corporate  |  Investor Relations  |  Platforms  |   Products / Pipeline  |  Business Development

 

 © 2007 Antares Pharma Inc. - All rights reserved.